A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation

Gastrointestinal Endoscopy

Volumn 68, Issue 2, 2008, Pages 294-300

  Abdul Baki, Heitham ^a   Hashash, Jana G ^a   ElHajj, Ihab I ^a   Azar, Cecilio ^a   El Zahabi, Lara ^a   Mourad, Fadi H ^a   Barada, Kassem A ^a   Sharara, Ala I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; MACROGOL; PLACEBO; TEGASEROD;

ABDOMINAL CRAMP; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOATING; CLINICAL TRIAL; COLON LAVAGE; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDOLES; IRRIGATION; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT COMPLIANCE; POLYETHYLENE GLYCOLS; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 47549097345     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.01.044     Document Type: Article

References (21)

1. Froehlich F., Wietlisbach V., Gonvers J.J., et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 61 (2005) 378-384
2. DiPalma J.A., Wolff B.G., Meagher A., et al. Comparison of reduced volume versus four liters sulfate-free electrolyte lavage solutions for colonoscopy colon cleansing. Am J Gastroenterol 98 (2003) 2187-2191
3. El Sayed A.M., Kanafani Z.A., Mourad F.H., et al. A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest Endosc 58 (2003) 36-40
4. Hookey L.C., Depew W.T., and Vanner S.J. A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am J Gastroenterol 99 (2004) 2217-2222
5. Kastenberg D., Chasen R., Choudhary C., et al. Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase III trials. Gastrointest Endosc 54 (2001) 705-713
6. Sharma V.K., Chockalingham S.K., Ugheoke E.A., et al. Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation. Gastrointest Endosc 47 (1998) 167-171
7. Vanner S.J., MacDonald P.H., Paterson W.G., et al. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (GoLYTELY) in the preparation of patients for colonoscopy. Am J Gastroenterol 85 (1990) 422-427
8. Aronchick C.A., Lipshutz W.H., Wright S.H., et al. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc 52 (2000) 346-352
9. Chan A., Depew W., and Vanner S. Use of oral sodium phosphate colonic lavage solution by Canadian colonoscopists: pitfalls and complications. Can J Gastroenterol 11 (1997) 334-338
10. DiPalma J.A., Buckley S.E., Warner B.A., et al. Biochemical effects of oral sodium phosphate. Dig Dis Sci 41 (1996) 749-753
11. Hookey L.C., Depew W.T., and Vanner S. The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc 56 (2002) 895-902
12. Lieberman D.A., Ghormley J., and Flora K. Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc 43 (1996) 467-469
13. Prather C.M., Camilleri M., Zinsmeister A.R., et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 118 (2000) 463-468
14. Degen L., Petrig C., Studer D., et al. Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17 (2005) 821-826
15. Sanaka M.R., Super D.M., Mullen K.D., et al. Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 23 (2006) 669-674
16. Ness R.M., Manam R., Hoen H., et al. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol 96 (2001) 1797-1802
17. Aoun E., Abdul-Baki H., Azar C., et al. A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation. Gastrointest Endosc 62 (2005) 213-218
18. Appel-Dingemanse S. Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity. Clin Pharmacokinet 41 (2002) 1021-1042
19. Morganroth J., Ruegg P.C., Dunger-Baldauf C., et al. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects. Am J Gastroenterol 97 (2002) 2321-2327
20. Muller-Lissner S., Kamm M.A., Musoglu A., et al. Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol 101 (2006) 2558-2569 quiz 2671
21. Lang L. The Food and Drug Administration permits restricted use of tegaserod maleate for qualifying patients. Gastroenterology 133 (2007) 1062-1063